Thyroid Flashcards

1
Q

Hormone Regulation

A

Bone formation- PTH: calcium, phosphorus
Growth formation- estrogens, androgens: testosterones; GHRH –> GH (Somatropin)
Metabolic rate control- TSH, thyroid hormone (TH)
BP and fluid balance control- cortisol, aldosterone, ADH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Human Growth Hormone

A

Somatropin (genotropin)

  • Recombinant DNA technology is true human factor
  • Stimulates the growth and metabolism of nearly every cell in the body
  • Uses: short stature with or without normal GH levels
  • – Contraindicated in patients with closed epiphyses
  • – Dosing is highly individualized on the basis of child’s growth rate and anticipated trajectory of genetic height
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Human Growth Hormone: Pharmacodynamics

A
  • Initially there is insulin-like effect
  • Stimulates growth of linear bones, skeletal muscles, and organs
  • Stimulates erythropoietin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Human Growth Hormone: Pharmacokinetics & ADRs

A

Pharmacokinetics: IM & SC drugs well-absorbed

  • Metabolism: hepatic, renal 90%
  • Excretion: renal

ADRs:

  • Antibody development
  • hyperglycemia, edema
  • hypothyroidism
  • arthralgia, HA, dizziness, flu-like symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Human Growth Hormone: Patient Education & Rational Drug Selection

A

Patient Education

  • Pediatric administration: total weekly dose (0.16 to 0.24 mg/kg) divided in 6-7 doses
  • ADRs
  • Lifestyle management and need to prevent abuse

Rational Drug Selection: Not initiated by NP in primary care practice; work with endocrinologist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Human Growth Hormone: Monitoring

A
  • Hepatic/renal function: before and during treatment

- TSH, glucose, glycohemoglobin, based on symptoms and prior illnesses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Thyroid Hormones: Pharmacodynamics

A

Levothyroxine (T4), Liothyronine (T3), and Liotrix (a 4:1 mixture of T4 & T3)

  • There hormones produce the same effects in the body as endogenous thyroid hormones
  • They also produce a negative feedback loop to reduce further secretion of TSH and thyroid hormones
  • T4 is the drug of choice for thyroid replacement and suppression therapy because of its longer half-life
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Thyroid Hormone: Pharmacokinetics

A

Absorption: oral- erratic 40-80%; decreased by age, food, health of GI tract; greater than 99% is protein bound

Metabolism: liver, T4 is converted to T3 in the body; T4 produces both hormones

Excreted: bile/feces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Thyroid Hormone: Precautions & Contraindications

A

Contraindicated after acute MI or thyrotoxicosis
Pregnancy risk factor A, and safe with children
- replacement is advised for all pregnant women
- increased metabolic rate during pregnancy may require higher dosing from baseline
- thyroid hormones are minimally excreted in breast milk
- Children with hypothyroidism need treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Thyroid Hormone: ADRs

A

Symptoms of hyperthyroidism:

  • CV: angina, increased BP, flushing, palpitations
  • Central nervous system: anxiety, HA, insomnia

Long-term thyroid replacement associated with decreased bone density in hip/spine in postmenopausal women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Thyroid Hormone: Drug Interactions

A

Bile-acid sequestrants, iron salts, and antacids decrease absorption; estrogens may decrease response

Drugs may decrease action of warfarin, digoxin, and beta blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hypothyroidism: Clinical Treatment

A

Treatment is indicated in patients with TSH levels greater than 10 or in patients with TSH levels between 5 and 10 in conjunction with goiter or positive antithyroid peroxidase antibodies (or both)

Thyroxine replacement is typically lifelong

Consult with pediatric endocrinologist before treating a pediatric patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

T4 Dosing: For patients with no known CV disease

A
  • Initial dose can be started at 50 mcg/day for 2 to 4 weeks and may be increased in increments of 25 mcg/day
  • Average full replacement 100-124 mcg/day
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

T4 Dosing: For patients 50+ years with CV disease or with long-standing hypothyroidism

A
  • Initial dosing of T4 is 12.5 to 25 mcg/day
  • An increase of 12.5 to 25 mcg increments at approximately 1 month intervals avoids rapid increases in cardiac workload and symptoms of ischemic heart disease
  • If exacerbations of angina pectoris occurs, the previous dosage regimen should be administered and titrated up in smaller increments
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

T4: Rational Drug Selection

A

T4 is drug of choice for thyroid replacement and suppression therapy

In older adults with no cardiac disease, consider consulting with endocrinologist regarding using T3 or T4 or liotrix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Thyroid Agents: Monitoring

A
  • TSH level should be measured in 6-8 weeks, and the T4 dose should be adjusted as necessary
  • The target TSH level should be between 0.3 and 3.0
  • Once a stable TSH level is achieved, annual examination is appropriate
  • Monitor for osteoporosis in high-risk populations
  • Many drugs affect TSH levels
17
Q

T4: Patient Education

A
  • Take medication each day in the morning, preferably before breakfast because absorption is increased on an empty stomach
  • ADRs: Learn how to measure heart rate
  • Lifestyle management is important
18
Q

Antithyroid Agents: Pharmacodynamics

A

Propylthiouracil (PTU), methimazole (Tapazole)

  • Both block synthesis of T4 and T3
  • Neither drug treats the underlying pathology in hyperthyroidism
  • High relapse rates exist but are less likely if treated for 18-24 months
19
Q

Antithyroid Agents: Pharmacokinetics

A

Absorption: rapidly absorbed after oral dosing, peaking within 1 hours: 85% to 95% bioavailability

PTU is 75% to 80% protein bound; methimazole is NOT protein bound

Both metabolized in the liver; both have short half-life; excreted in urine: 35% of PTU, 80% of methimazole

20
Q

Antithyroid Agents: Precautions, Contraindications, ADRs, & Drug Reaction

A

Precautions & Contraindications

  • Pregnancy major concern: readily cross the placenta
  • – Recommend that patient not get pregnant while on these drugs
  • High concentrations in breast milk
  • PTU not recommended in children

ADRs: agranulocytosis, drowsiness, HA, alopecia, skin rashes, renal/hepatic failure
Drug Reaction: lithium, warfarin

21
Q

Antithyroid Agents: Rational Drug Selection & Monitoring

A

Rational Drug Selection
- Check guidelines, as use in pregnancy and children varies frequently

Monitoring

  • Thyroid studies, CBC, liver/renal panels before starting drug
  • Recheck in 1-2 months after starting drug
22
Q

Antithyroid Agents: Patient Education

A
  • Administration: very important to NOT miss doses; if dose is missed, patient should NOT make up dose
  • Teach about hypothyroid symptoms; prolonged subclinical hyperthyroidism is associated with bone loss, a. fib., and impaired left ventricular diastolic filling
  • Dietary sources of iodine should be reduced because they interfere with action of drugs
  • Watch use of OTC cold medicines
23
Q

Posthyperthyroid Treatment

A

Patients need to expect that they will become hypothyroid

This may not occur for several months

Patients must take thyroid supplements for life